Anthera suspends PEARL-SC after vial problem

Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) suspended enrollment and dosing in the Phase IIb PEARL-SC trial of A-623 due to cracked vials of the lupus candidate. Anthera said there have been no reports...